The Coronary Drug Project. Organizational structure of the study.
P L Canner, J Stamler
https://pubmed.ncbi.nlm.nih.gov/6675888/Completed
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2013-11-26
N/A
Participants Needed
N/A
Research Sites
N/A
Total Duration
To determine whether there were any long term sequelae of the drugs used in the Coronary Drug Project (estrogens, dextrothyroxine, nicotinic acid, clofibrate).
CONDITIONS
Coronary Drug Project Mortality Surveillance
Site Locations not provided
Location information for this trial is currently unavailable.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Heart, Lung, and Blood Institute (NHLBI)
Lead Sponsor
No eligibility criteria
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
RANDOMIZED
Model
N/A
Primary Purpose
PREVENTION
Number of Arms
0
P L Canner, J Stamler
https://pubmed.ncbi.nlm.nih.gov/6675888/P L Canner, K G Berge, N K Wenger...
https://pubmed.ncbi.nlm.nih.gov/3782631/K G Berge, P L Canner
https://pubmed.ncbi.nlm.nih.gov/2044644/P L Canner, C R Klimt
https://pubmed.ncbi.nlm.nih.gov/6675887/National Heart, Lung, and Blood Institute (NHLBI)
Lead Sponsor